• Working across distinct fields within medicine - clinical trials, epidemiology & machine learning
  • Previously worked in academia, government & industry - startups, multinationals & freelance consultant
  • Raised in Australia but have lived/worked/studied in Europe & North America

Main research areas


  • PhD Medicine, University of Alberta, Canada
  • MSc Clinical Research, Cardiff University, Wales
  • MSc Biometry, University of Reading, England
  • First Class Hons Mathematics, Griffith University, Australia

Papers & Code

Examining the Influence of Component Outcomes on the Composite at the Design Stage

While the literature simultaneously promotes and condemns composite endpoints, they are often used as the primary end point in clinical …

Frailty modelling for multitype recurrent events in clinical trials

Recurrent event outcomes are ubiquitous among clinical trial data which encourages a conventional approach to analysis. Yet a common …

Power and Sample Size Estimation for Composite Endpoints: Practical Implementation using Data Simulations

Composite endpoints are a popular outcome in controlled studies. However, the required sample size is not easily obtained due to the …

Multitype Events and the Analysis of Heart Failure Readmissions: Illustration of a New Modeling Approach and Comparison With Familiar Composite End Points

Heart failure–related hospital readmissions and mortality are often outcomes in clinical trials. Patients may experience multiple …